Scientists hunt genetic clues to why some survive heart shock while others Don't

NCT ID NCT05728359

Recruiting now Knowledge-focused Sponsor: Barts & The London NHS Trust Source: ClinicalTrials.gov ↗

Summary

This study aims to understand why patients with cardiogenic shock (a severe form of heart failure) respond differently to treatments and have varying outcomes. Researchers will collect blood samples from 300 patients across Europe to analyze genetic patterns and immune system responses. The goal is to identify biological markers that could help predict outcomes and guide future treatment development.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Barts Health NHS trust
RECRUITING

London, United Kingdom

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARDIOGENIC SHOCK